Laurent Victor-Michel

Kirkland & Ellis is advising Thomas H. Lee Partners, Frazier Healthcare Partners and Adare Pharma Solutions on entering exclusive negotiations on the potential sale of Adare Biome, a pioneer in the development and manufacturing of postbiotics, to Royal DSM. Read Adare Pharma Solutions’ press release The Kirkland team is led by corporate partners Laurent Victor-Michel, Emmanuel Enrici, Christopher Elder and Andrew Struckmeyer and associates François Capoul and Guillaume Nivault; tax partners Sonia Bouaffassa and Sehj Vather and associate Grant Newman; and technology & IP transactions partner John Patten and associates Colin Russell and Alex Zapalowski.

May 11

1 min

Kirkland & Ellis is advising EQS Group as it enters into exclusive negotiations for the acquisition of French company Data Legal Drive, a key player in the GDPR and anti-corruption compliance software market. EQS is an international cloud software provider for corporate compliance, investor relations and sustainability reporting and a portfolio company of Thoma Bravo. The transaction is expected to finalise in the coming weeks. Read EQS’s Press Release The Kirkland team is being led by corporate partner Laurent Victor-Michel and associate Etienne Vautier; debt finance partner Kirsteen Nicol and associates Adrian Kilercioglu and Igor Musienko; and antitrust & competition partners Matthew Sinclair-Thomson and Kelsey Laugel and associate Ankita Gulati.

Jul 10

1 min

Kirkland & Ellis is advising Blue Wolf Capital Partners, a middle market private equity firm specialising in the industrial and healthcare sectors, on its acquisition of Synerlab, a contract development and manufacturing organisation based in Strasbourg, France, with six operating facilities in France and Spain. Following regulatory approvals, the transaction is expected to close in Q4 2024. The Kirkland team includes corporate lawyers Louis Gosset, Laurent Victor-Michel, Nick Appleton, Jacob Traff, Amanda Levi Acobas and Jack Evans; and antitrust & competition lawyer Aakarsh Narula.

Oct 11

1 min

Kirkland & Ellis is advising co-controlling shareholders WP GG Holdings IV B.V., an affiliate of Warburg Pincus, and ARCHIMED on the sale of Polyplus for approximately €2.4 billion to Sartorius, a life science group. Polyplus was initially acquired by ARCHIMED in 2016, which sold half of its stake to Warburg Pincus in 2020. Polyplus is a global provider of upstream bioprocessing solutions, including transfection reagents and DNA plasmids, which are critical inputs used in the manufacturing of cell and gene therapies. Kirkland advised Warburg Pincus and Dechert advised ARCHIMED on the 2020 acquisition. Read Sartorius’ press release The Kirkland team is led by corporate partners Laurent Victor-Michel and Adrian Maguire and associates Guillaume Nivault, Etienne Vautier, Luke Forryan, Nikhil Mohindra and Lucy Bower; antitrust partners Marin Boney and Matthew Sinclair-Thomson and associate Miata Eggerly; and tax partners Nadine Gelli, Peter Abbott and Sonia Bouaffassa and associate Maria Clezy.

Apr 3

1 min

Kirkland & Ellis advises MACOM Technology Solutions Holdings, Inc., a supplier of semiconductor products, on its acquisition of the key manufacturing facilities, capabilities and technologies of OMMIC SAS. Going forward, the facility, which is located near Paris in Limeil-Brévannes, France, will become the foundation for MACOM’s newly established European Semiconductor Center. Read MACOM’s press release The Kirkland team was led by corporate partner Laurent Victor-Michel and associates Lucy Bower and Amanda Levi-Acobas; tax partner Nadine Gelli and associate Louise Chappey; international trade & national security partners Ivan Schlager and Daniel Gerkin; and antitrust associate Juan Donado-Diez.

Jun 5

1 min